Nuropod has announced a professional partnership program for practitioners and clinics, offering access to CPD-accredited AVNT™ education through the Parasym Scientific Network, device trial opportunities, and direct contact with the research team.
-- Nuropod has opened its professional partnership program to practitioners and clinics across the United States, providing access to its wearable vagus nerve stimulation technology, CPD-accredited training, onboarding support, and clinical implementation guidance.
More information is available at https://nuropod.com/pages/for-professionals
The announcement comes as more practices look for non-invasive services they can offer in the clinic and that clients can continue between appointments at home. Nuropod’s program aims to address this demand, pairing direct access to Parasym’s science and research team with a device backed by more than 60 completed clinical studies, including randomized, placebo-controlled research.
For individual practitioners, the program operates through Nuropod’s Healthcare Professional Program, which invites members to join the Parasym Scientific Network. Participants can learn about the studies, science, and recommended protocols behind Parasym’s proprietary AVNT™ waveform and become AVNT practitioners through CPD-accredited education. The program also offers opportunities to trial the device with users and direct access to the scientific research team. Practitioners apply through an online form on the professionals page.
For clinics and medical spas, the program introduces non-invasive vagal neuromodulation alongside existing services. Sessions can run without consumables, and clients can continue at home between appointments through designated continuation protocols, which the company says supports client retention. Partner practices also receive dedicated professional pricing.
A separate Parasym Research Network serves researchers. Members gain access to publications and peer-reviewed studies, can collaborate on research opportunities in shared fields of interest, and can inquire directly about potential research partnerships. Athletes and performance professionals are directed to a dedicated performance site.
Nuropod is trusted by more than 1,000 healthcare professionals and has recorded over 5 million user sessions. Its underlying technology reflects more than 10 years of research and development, with over 100 clinical studies currently underway.
Practitioners and clinics can apply or request partnership details at https://nuropod.com/
Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-significant risk device and is not intended to diagnose, treat, cure, or prevent any disease.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nuropod by Parasym
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/
Source: PressCable
Release ID: 89208237
Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.
